Pulmonary vascular disease & thromboembolismCohort study

Mechanical Thrombectomy and Catheter-Directed Thrombolysis in Acute Pulmonary Embolism

J Am Coll CardiolPublished

  • Prospective registry study
  • multicentre
  • 48 US institutions
  • mixed-effects models

Authors' conclusion

Over the past decade, MT has rapidly replaced CDT as predominant catheter-based therapy for acute PE, reflecting both technological innovation and evolving operator confidence.

Study context

Population
Intermediate- or high-risk acute pulmonary embolism (PE) treated with advanced therapies, Pulmonary Embolism Response Team (PERT) Consortium Registry, 2016–2024
Participants
2,958 participants · 48 US institutions
Exposure
Mechanical thrombectomy (MT) vs catheter-directed thrombolysis (CDT)
Outcome
Temporal trends in use of systemic thrombolysis, CDT and MT
Follow-up
2016 to 2024

Main finding

Temporal trends in use

Incidence rate ratio

1.18

95% CI 1.14–1.23

MT
IRR 1.18 (95% CI 1.14–1.23)

Per year, as printed

As reported in the abstract

CDT use declined per year
13%
Systemic thrombolysis use declined per year
12%

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
Factors associated with MT vs CDT — MT vs CDT · age ≥70 years1.37 (1.04–1.81)
Factors associated with MT vs CDT — MT vs CDT · male sex1.54 (1.19–1.99)

Factors associated with MT vs CDT

MT also associated with vasopressor use, ECMO support, saddle embolus or clot in transit; CDT more often in younger female patients and with cardiorespiratory symptoms

Risk category of treated patients

Intermediate-risk PE
75.9%
High-risk PE
24.1%
Proportion of high-risk patients and mean Composite Pulmonary Embolism Score (CPES) increased over the study period

Original publication

Mechanical Thrombectomy and Catheter-Directed Thrombolysis in Acute Pulmonary Embolism. J Am Coll Cardiol. Published 25 February 2026. doi:10.1016/j.jacc.2025.12.073

Summarised from the published abstract; every number is checked against it